• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of external presentations facilitating development of MCM to Advisory Committees, Workshops, Professional Society meetings, etc. in the quarter

Dictionary: CBER makes presentations at public meetings to facilitate biologics development on medical countermeasures (MCM) against the effects of chemical, biological, radiological, and nuclear (CBRN) agents. This measure is the number of external presentations by CBER staff at meetings sponsored by professional societies, consortia, academia, or other government entities in that quarter.

Information is current as of September 30, 2013.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetValue
Oct-Dec 2012N/A26
Jan–Mar 2013N/A9
Apr–Jun 2013N/A36
Jul-Sept 2013N/A28

FY 2013 Total: 99

Footnotes

  • The CBER program measures will be reported on a quarterly basis with the data shown on the third month of the quarter. There are no fiscal year targets established.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.